Medigene AG (MDG1) — Net Asset Quality Index
Medigene AG (MDG1) has a Net Asset Quality Index of 68.2% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €28.81 Million minus total liabilities of €9.15 Million yields net assets of €19.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Medigene AG (MDG1) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medigene AG Net Asset Quality Index Over Time (2006–2023)
This chart shows how Medigene AG's Net Asset Quality Index has evolved across 18 annual periods from 2006 to 2023. As of June 2024, the index stands at 68.2%, representing net assets of €19.66 Million against total assets of €28.81 Million EUR. See Medigene AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Medigene AG (2006–2023)
The table below presents the year-by-year Net Asset Quality Index for Medigene AG from 2006 to 2023, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Medigene AG.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 66.4% | €21.07 Million | €31.72 Million | €10.65 Million | ▼ -5.2 pp |
| 2022 | 71.6% | €37.03 Million | €51.68 Million | €14.65 Million | ▼ -3.7 pp |
| 2021 | 75.4% | €44.82 Million | €59.47 Million | €14.65 Million | ▲ +4.3 pp |
| 2020 | 71.1% | €53.15 Million | €74.75 Million | €21.60 Million | ▼ -3.8 pp |
| 2019 | 74.9% | €81.82 Million | €109.22 Million | €27.39 Million | ▼ -8.0 pp |
| 2018 | 82.9% | €107.42 Million | €129.59 Million | €22.16 Million | ▲ +5.9 pp |
| 2017 | 77.0% | €86.17 Million | €111.94 Million | €25.77 Million | ▲ +6.6 pp |
| 2016 | 70.4% | €78.59 Million | €111.72 Million | €33.12 Million | ▼ -8.9 pp |
| 2015 | 79.3% | €89.99 Million | €113.53 Million | €23.54 Million | ▲ +10.4 pp |
| 2014 | 68.8% | €49.07 Million | €71.28 Million | €22.21 Million | ▼ -0.1 pp |
| 2013 | 68.9% | €36.28 Million | €52.66 Million | €16.38 Million | ▼ -3.3 pp |
| 2012 | 72.2% | €44.22 Million | €61.26 Million | €17.04 Million | ▼ -17.8 pp |
| 2011 | 89.9% | €47.93 Million | €53.29 Million | €5.36 Million | ▲ +19.8 pp |
| 2010 | 70.1% | €40.80 Million | €58.20 Million | €17.40 Million | ▼ -8.8 pp |
| 2009 | 78.9% | €51.87 Million | €65.72 Million | €13.85 Million | ▼ -1.5 pp |
| 2008 | 80.4% | €64.91 Million | €80.75 Million | €15.84 Million | ▼ -9.3 pp |
| 2007 | 89.7% | €103.09 Million | €114.93 Million | €11.84 Million | ▲ +2.3 pp |
| 2006 | 87.4% | €108.51 Million | €124.14 Million | €15.62 Million | — |